Agilysys officer plans $688K sale of shares

AGILYSYS INC (AGYS) received a notice under Rule 144 for a planned sale of its common stock by officer William David Wood III.

Rhea-AI Filing Summary

AGILYSYS INC (AGYS) received a notice under Rule 144 for a planned sale of its common stock by officer William David Wood III. The notice lists 6,000 common shares in connection with a prospective sale through Fidelity Brokerage Services LLC, with an indicated date of 08/18/2026 and NASDAQ as the trading venue.

The filing details that the 6,000 shares relate to compensation awards, including a stock appreciation right dated 01/27/2023 and multiple restricted stock vesting events scheduled between 06/30/2024 and 10/31/2025. No sales in the past three months are reported in this notice.

Key Figures

Common shares: 6,000 shares Associated value figure: $688,324.16 Prospective sale date: 08/18/2026 +5 more

8 metrics

Common shares 6,000 shares Listed in connection with a prospective sale through Fidelity Brokerage Services LLC

Associated value figure $688,324.16 Figure listed in the securities information row for the 6,000 common shares

Prospective sale date 08/18/2026 Date shown in the securities information section for the common shares entry

Stock appreciation right shares 1,740 shares Common shares tied to a SAR dated 01/27/2023 classified as compensation

Restricted stock vesting 06/30/2024 369 shares Common shares from restricted stock vesting on 06/30/2024, compensation-related

Restricted stock vesting 10/31/2024 1,397 shares Common shares from restricted stock vesting on 10/31/2024, compensation-related

Restricted stock vesting 06/30/2025 744 shares Common shares from restricted stock vesting on 06/30/2025, compensation-related

Restricted stock vesting 10/31/2025 1,750 shares Common shares from restricted stock vesting on 10/31/2025, compensation-related

Key Terms

Rule 144, Stock Appreciation Right, Restricted Stock Vesting, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Appreciation Right financial

"Common | 01/27/2023 | SAR | Issuer |"

A stock appreciation right (SAR) is a form of employee pay that gives the holder the right to receive the increase in a company's share price over a set reference price, paid in cash or shares, without having to buy stock first. It matters to investors because SARs can create future cash outflows or dilute existing shareholders if settled in stock, and they align employee incentives with share-price performance like a bonus tied to a home's price rise.

Restricted Stock Vesting financial

"Common | 06/30/2024 | Restricted Stock Vesting | Issuer |"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for William Wood."

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for AGYS and William David Wood III?

The Form 144 indicates an intention to sell 6,000 AGYS common shares by officer William David Wood III. These shares stem from compensation awards, including stock appreciation rights and restricted stock vesting events between 2023 and 2025.

How many AGYS shares are covered by this Rule 144 notice?

The notice covers 6,000 AGYS common shares in connection with a potential sale through Fidelity Brokerage Services LLC. The shares are tied to prior compensation grants, including a stock appreciation right and several restricted stock vesting events.

When could the AGYS shares listed in the Form 144 be sold?

The filing lists a prospective sale date of 08/18/2026 for the 6,000 AGYS common shares. This date appears alongside NASDAQ as the trading venue in the securities information section of the notice.

Through which broker are the AGYS shares expected to be sold?

The Form 144 identifies Fidelity Brokerage Services LLC as the broker for the potential sale of 6,000 AGYS common shares. Fidelity’s address in Smithfield, Rhode Island, is listed in the securities information section.

What is the origin of the 6,000 AGYS shares listed in the Form 144?

The 6,000 AGYS shares are linked to compensation awards, including a stock appreciation right dated 01/27/2023 and restricted stock vesting events on 06/30/2024, 10/31/2024, 06/30/2025, and 10/31/2025.

Does the Form 144 for AGYS report any recent share sales?

No recent sales are listed; the section for securities sold during the past three months does not report transactions. The notice focuses on the planned sale of 6,000 AGYS common shares tied to prior compensation grants.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 02:15 PM Accepted by SEC EDGAR 08/18/2026 - 02:14 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001820468
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AGILYSYS INC
SEC File Number	000-05734
Address of Issuer	3655 BROOKSIDE PARKWAY SUITE 300 ALPHARETTA GEORGIA 30022
Phone	7708107800
Name of Person for Whose Account the Securities are To Be Sold	Wood William David III
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6000	688324.16	28205788	08/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/27/2023	SAR	Issuer			1740	01/27/2023	Compensation
Common	06/30/2024	Restricted Stock Vesting	Issuer			369	06/30/2024	Compensation
Common	10/31/2024	Restricted Stock Vesting	Issuer			1397	10/31/2024	Compensation
Common	06/30/2025	Restricted Stock Vesting	Issuer			744	06/30/2025	Compensation
Common	10/31/2025	Restricted Stock Vesting	Issuer			1750	10/31/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jessica Spraker, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for William Wood.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)